載入...
Pirfenidone Is Renoprotective in Diabetic Kidney Disease
Although several interventions slow the progression of diabetic nephropathy, current therapies do not halt progression completely. Recent preclinical studies suggested that pirfenidone (PFD) prevents fibrosis in various diseases, but the mechanisms underlying its antifibrotic action are incompletely...
Na minha lista:
Main Authors: | , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
American Society of Nephrology
2009
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2723978/ https://ncbi.nlm.nih.gov/pubmed/19578007 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2008090931 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|